Elżbieta Grześk Sylwia Kołtan Anna Dąbrowska Anna Urbańczyk Jadwiga Małdyk Bogdan Małkowski Tomasz Bogiel Robert Dębski Krzysztof Czyżewski Mariusz Wysocki Jan Styczyński
10.3389/fimmu.2022.915986
Front Immunol
2022 Aug 5;13:915986.
allo-hct cvid - common variable immunodeficiency disorders ebv-ctls ebv-specific cytotoxic t cells hv-lpd ngs - next generation sequencing allogeneic hematopoietic stem cell transplantation
CC BY
https://pubmed.ncbi.nlm.nih.gov/35990691/
Common Variable Immunodeficiency / complications Common Variable Immunodeficiency / therapy Epstein-Barr Virus Infections / complications Epstein-Barr Virus Infections / therapy Hydroa Vacciniforme / diagnosis Hydroa Vacciniforme / therapy Lymphoproliferative Disorders / diagnosis Lymphoproliferative Disorders / etiology Lymphoproliferative Disorders / therapy Skin Neoplasms
Common Variable Immunodeficiency / complications Common Variable Immunodeficiency / therapy Epstein-Barr Virus Infections / complications Epstein-Barr Virus Infections / therapy Hydroa Vacciniforme / diagnosis Hydroa Vacciniforme / therapy Lymphoproliferative Disorders / diagnosis Lymphoproliferative Disorders / etiology Lymphoproliferative Disorders / therapy Skin Neoplasms Case Reports Research Support, Non-U.S. Gov't Child Herpesvirus 4, Human Humans
PMC9390486
35990691
Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
2022